Showing 1 - 20 results of 49 for search 'Ferrata Storti Foundation', query time: 0.03s Refine Results
  1. 1
    Introduction to the Review Series on Myelodysplasia

    Introduction to the Review Series on Myelodysplasia by Moshe Mittelman

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Context and timing matters in acute myeloid leukemia: females are the superior hosts

    Context and timing matters in acute myeloid leukemia: females are the superior hosts by Kerstin B. Kaufmann, Stephanie Z. Xie

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV study

    Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV s... by Muhit Özcan, Ryan D. Cassaday, Ewa Zarzycka, Erik Vandendries, Fan Zhang, Ying Chen, Alejandra Nieto, Fatih Demirkan, Pau Montesinos, Fevzi Altuntas

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy

    The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy by Jinlan Long, Shufeng Xie, Wenjie Zhang, Weiyu Dou, Yixin Wang, Ruiheng Wang, Han Liu, Zhenshu Xu

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Heat exposure and pediatric immune thrombocytopenia in Japan from 2011 to 2022: a nationwide space-time-stratified case-crossover study

    Heat exposure and pediatric immune thrombocytopenia in Japan from 2011 to 2022: a nationwide space-time-stratified case-crossover study by Nobutoshi Nawa, Hisaaki Nishimura, Kiyohide Fushimi, Takeo Fujiwara

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies

    Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a st... by Qian Yan, Jinlin Liu

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

    Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative n... by Ali Alsugair, Saubia Fathima, Fnu Aperna, Naseema Gangat, Ayalew Tefferi

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Recipient sex and donor leukemic cell characteristics determine leukemogenesis in patient-derived models

    Recipient sex and donor leukemic cell characteristics determine leukemogenesis in patient-derived models by Anna MP. Stanger, Marlon Arnone, Pauline Hanns, Lucca M. Kimmich, Jessica Kübler, Sarah Gekeler, Elsa S. Görsch, Lea Kramer, Marcelle Baer, Jan C. Schroeder, Taylor S. Mills, Martina Konantz, Saskia S. Rudat, Claudia Lengerke

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapies

    High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to stand... by Yousef Laham, Shimrit Ringelstein-Harlev, Daniel Kurnik, Riva Fineman, Dana Yehudai-Ofir, Lilach Bonstein, Noga Setter-Marco, Eyal Braun, Itai Ghersin, Tsila Zuckerman, Ofrat Beyar-Katz

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies

    Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies by Sheryl Y. T. Lim, Frances M. Cole, George S. Laszlo, Margaret C. Lunn-Halbert, Jenny Huo, Junyang Li, Allie R. Kehret, Roland B. Walter

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study

    Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study by Matteo Dragani, Michela Ansuinelli, Cristina Papayannidis, Nicola Fracchiolla, Valeria Cardinali, Michele Cedrone, Fabio Guolo, Salvatore Perrone, Prassede Salutari, Elisabetta Todisco, Robin Foà, Sabina Chiaretti

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Very long-term remission with azacitidine in VEXAS syndrome

    Very long-term remission with azacitidine in VEXAS syndrome by Lin-Pierre Zhao, Vincent Jachiet, Olivier Kosmider, Lise Larcher, Emmanuelle Clappier, Marie Sébert, Lionel Adès, Pierre Hirsch, Thibault Mahévas, Maxime Battistella, Jean-David Bouaziz, Arsène Mekinian, Pierre Fenaux, MINHEMON FRENVEX

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)

    Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02) by Sarah Bertoli, Emilie Bérard, Pierre Peterlin, Romain Guieze, Yohan Desbrosses, Yosr Hicheri, Omar Benbrahim, Martin Carre, Corentin Orvain, Anne Banos, Marc Bernard, Emmanuel Gyan, Alain Saad, Safia Chebrek, Gabrielle Roth Guepin, Veronique Dorvaux, Laurence Sanhes, Maria Pilar Gallego-Hernanz, Carole Exbrayat, Laure Vincent, Chantal Himberlin, Célestine Simand, Norbert Vey, Cindy Fenoll, Ariane Mineur, Anne Huynh, Francois Vergez, Isabelle Luquet, Laetitia Largeaud, Eric Delabesse, Arnaud Pigneux, Christian Récher, French Innovative Leukemia Organization FILO

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Ethnicity in systemic AL amyloidosis may impact risk stratification

    Ethnicity in systemic AL amyloidosis may impact risk stratification by Jahanzaib Khwaja, Sriram Ravichandran, Oliver Cohen, Darren Foard, Ana Martinez – Naharro, Lucia Venneri, Carol Whelan, Philip N. Hawkins, Julian Gillmore, Helen J. Lachmann, Shameem Mahmood, Marianna Fontana, Ashutosh Wechalekar

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    H2-K1 protects murine MLL-AF9 leukemia stem cells from natural killer cell-mediated immune surveillance

    H2-K1 protects murine MLL-AF9 leukemia stem cells from natural killer cell-mediated immune surveillance by Somadri Ghosh, Maria Rodriguez-Zabala, Gladys Telliam Dushime, Katrin Reinbach, Ramprasad Ramakrishnan, Ewa Sitnicka, Marcus Järås, Lymphoid Development and Regulation

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Emerging technologies of single-cell multi-omics

    Emerging technologies of single-cell multi-omics by Yi June Kim, Koichi Takahashi

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologists

    Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologists by Dong Li, Sarah K. Tasian, Gerald Wertheim, Susan R. Rheingold, Kathrin M. Bernt, Haley Newman, Luanne Wainwright, Donna M. Wilmoth, Brian Thiel, Lea F. Surrey, Elizabeth Margolskee, Vinodh Pillai, Minjie Luo, Michele E. Paessler, Stephen P. Hunger, Marilyn M. Li, Yiming Zhong

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study

    Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study by Barbara Gianesin, Frédéric B. Piel, Khaled M. Musallam, Susanna Barella, Maddalena Casale, Elena Cassinerio, Rosario Di Maggio, Antonia Gigante, Maria Rita Gamberini, Giovanna Graziadei, Roberto Lisi, Filomena Longo, Aurelio Maggio, Raffaella Origa, Annamaria Pasanisi, Silverio Perrotta, Antonio Giulio Piga, Valeria Maria Pinto, Rosamaria Rosso, Giacomo Robello, Giovanna Russo, Marco Zecca, Lucia De Franceschi, Gian Luca Forni, Italian Hemoglobinopathies National Survey Group

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Alessandro Pileri: an enthusiastic pioneer of modern hematology

    Alessandro Pileri: an enthusiastic pioneer of modern hematology by Mario Boccadoro, Paolo Corradini, Massimo Massaia, Corrado Tarella

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Opportunistic bone density assessment using pre-treatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy

    Opportunistic bone density assessment using pre-treatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy by Genevieve Douglas, Kane M. Nicholls, Erin Paul, Zoe Loh, Sze-Ting Lee, Kathryn L Hackman, Cherie Chiang, Niamh Waters, Geoffrey Chong, Ashvind Prabahran, Eliza A. Hawkes

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: